Arecor Therapeutics raising £6m to acquire diabetes medicine specialist Tetris Pharma
Arecor Therapeutics is raising about £6million to acquire Tetris Pharma.
Closed Loop Medicine appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer
Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that enable personalised dose optimisation, announces it has appointed David Van Sickle PhD as Non-Executive Director and Simon Ramsden as Chief Financial Officer.
Wazoku named as one of the UK’s Best Workplaces™ for Women
Innovation scale-up placed at 22 in the medium-sized business category, cited for its ongoing commitment to fair representation of women in the workplace
Arecor goes from strength to strength
Upbeat Arecor Therapeutics, the Cambridge biopharma company, reveals it is continuing discussions with potential partners to expand its portfolio of revenue generating partnership deals.
Featurespace Appoints Carolyn Homberger as its President of the Americas
Featurespace™, the leading provider of Enterprise Fraud and Financial Crime Prevention software, has appointed Carolyn Homberger as its President of the Americas.
Healx opens second facility with new lab at Chesterford Research Park
Healx, an AI-powered company pioneering the next generation of drug discovery for rare diseases, is taking more than 3,500 sq ft of space within Chesterford Research Park’s multi-occupancy lab building.
Privitar announces Kormoon acquisition extending data privacy and provisioning capabilities
Privitar, the leader in modern data provisioning, today announced it has acquired Kormoon, a software platform that helps organizations manage the complexities of data privacy regulations by analyzing data usage, assessing risk, and automating compliance.
Paragraf plans to develop graphene-based in-vitro diagnostic products
Paragraf will develop a proof-of-concept combined PCT and CRP test that will differentiate between bacterial and other infections.
Van Oord taps Rovco for Hollandse Kust Noord subsea work
UK-based Rovco has signed a contract with Van Oord to carry out subsea investigation works on the 759 MW Hollandse Kust Noord offshore wind farm in the Dutch Sea.
Offshore tech company Rovco to carry out unexploded ordnance investigations on Dutch wind farm
The Bristol-based firm will use its tech to generate 3D models of unexploded items
Tripism CEO Kerr Assesses Travel Management Evolution
Business travel booking and planning platform Tripism this month reported activity levels on its platform are now 250 percent higher than their previous pre-Covid-19 high point.
Rare cancer research firm RareCan seals six-figure investment to drive business growth
The Hexham startup places patients and data at the heart of research, to find better ways to prevent, diagnose and treat rare cancer
Perks, cash and an eye on the US for digital health doyen Boutros Bear
Cambridge digital health startup Boutros Bear is on the cusp of taking a new funding round to £1.95 million and has its eyes on expansion into the US.
52 North Health and University of Cambridge awarded £200,000 to help translate research
52 North Health and the University of Cambridge have been awarded £200,000 under Innovate UK’s Knowledge Transfer Partnership (KTP) programme.
Flusso engineer wins major research award
Dr Ethan Gardner, one of the youngest R & D engineers with Cambridge-based fabless semiconductor company Flusso – a Cambridge University spin-out – has won a major UK honour.
Psyomics wins £2.4m to broaden mental health platform across NHS
Cambridge healthtech company Psyomics has closed a £2.4 million funding round as it continues to expand access to its online mental health assessment platform to individual users and NHS trusts.
Crowd-funding publisher Unbound appoints new CEO
Unbound, the award-winning independent crowd-funding publisher, has enjoyed a year of remarkable growth and appointed a new CEO: Wil Harris.
Tripism experiences rapid growth as return to travel brings challenges and opportunities for the corporate travel industry
Tripism, the business travel planning and engagement platform, is reporting exponential user growth as corporate travel teams scramble to deal with the rapid return to business travel in 2022.
Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer
Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors.
CyberSmart Partners with Vodafone Ireland to Enable Secure Connectivity for SMEs
CyberSmart, a UK leader in simple and accessible automated cybersecurity technology for small and medium sized enterprises (SMEs), has today announced its strategic partnership with Vodafone Ireland.